★ Sign in to follow
OA

OncoZenge AB (publ) Stock: price and insider trades · Sweden

ISIN SE0015531223SE·

No insider purchase over the last 90 days. The latest, by Pirkko Vilja Päivikki Sulila Tamsen, was filed 05 Mar 2021.

OncoZenge AB (publ): what insiders have been doing

Every trade that managers of OncoZenge AB (publ) disclose to Finansinspektionen is tracked on this page. OncoZenge AB (publ) has had no insider filing for more than a year; the last one goes back to 10 March 2021.

The full history, which starts in 2021, counts 2 purchases against 4 sales.

For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
12
Thresholds
n/a
Buy Volume
€15,175
2 ops. · all time
Sell Volume
€17,927
4 ops. · all time

Financial data

· cache

Last declaration on 10 March 2021
Declarations12 total
  • ●
    Mattias Klintemar
    StyrelseledamotExecutives
    0FI-SE
    1 shares0Teckningsrätt/UniträttFI:csv-b87a048aa5482cb5f9b4
  • ●
    Torben Mogensen
    StyrelseledamotExecutives
    108,988 SEK0FI-SE
    10,633 shares@ SEK 10.25100.0% of flowBTA (betald tecknad aktie)ISIN SE0015531231FI:csv-c1d39cf6ede3dde30e9c
  • ●
    Pirkko Vilja Päivikki Sulila Tamsen
    Verkställande direktör (VD)Executives
    0FI-SE
    335 shares0Teckningsrätt/UniträttISIN SE0015531223FI:csv-d503c843e190e0d23f21
  • ●
    Cindy Wong
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
    205,000 SEK0FI-SE
    20,000 shares@ SEK 10.25100.0% of flowBTA (betald tecknad aktie)ISIN SE0015531231FI:csv-fb8b2448194b2a7c5123
  • ●
    Anna Helena Constance Ljung
    StyrelseordförandeExecutives
    100,009 SEK0FI-SE
    9,757 shares@ SEK 10.25100.0% of flowBTA (betald tecknad aktie)ISIN SE0015531231FI:csv-776e52e711c658828698
  • ●
    Pirkko Vilja Päivikki Sulila Tamsen
    Verkställande direktör (VD)Executives
    205,000 SEK0FI-SE
    20,000 shares@ SEK 10.2539.9% of flowBTA (betald tecknad aktie)ISIN SE0015531231FI:csv-0bab96b5a25ebba05a89
  • ▲
    Pirkko Vilja Päivikki Sulila Tamsen
    Verkställande direktör (VD)Executives
    154,429 SEK25FI-SE
    13,900 shares@ SEK 11.1130.0% of flowAktieISIN SE0015504097FI:csv-c0267224901fef25fd31
    Canonical exit: 3 Jun 2021 (T+90)
  • ▼
    Pirkko Vilja Päivikki Sulila Tamsen
    Verkställande direktör (VD)Executives
    154,199 SEK0FI-SE
    134,086 shares@ SEK 1.1530.1% of flowTeckningsrätt/UniträttISIN SE0015531223FI:csv-21c872634d5e6815314c
  • ▼
    Mark Beveridge
    Ekonomichef/finanschef/finansdirektörExecutives
    11,111 SEK0FI-SE
    9,259 shares@ SEK 1.2040.0% of flowTeckningsrätt/UniträttISIN SE0015531223FI:csv-4067e190098200ad63f9
  • ▼
    Mark Beveridge
    Ekonomichef/finanschef/finansdirektörExecutives
    16,658 SEK0FI-SE
    15,144 shares@ SEK 1.1060.0% of flowTeckningsrätt/UniträttISIN SE0015531223FI:csv-b42c5962a22961cd09e7
  • ▼
    Pirkko Vilja Päivikki Sulila Tamsen
    Verkställande direktör (VD)Executives
    0FI-SE
    41,135 shares0Teckningsrätt/UniträttISIN SE0015531223FI:csv-02909e562cae4f314e4c
  • ▲
    Cindy Wong
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
    0FI-SE
    20,000 shares0Teckningsrätt/UniträttISIN SE0015531223FI:csv-965cac4ffdf0d991e68d
    Canonical exit: 20 May 2021 (T+90)

12 of 12 declarations

About OncoZenge AB (publ)

OncoZenge AB (publ) is a publicly traded company on the XSTO market, focused on developing innovative cancer treatments. It aims to provide therapeutic solutions that enhance the quality of life for patients.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations

Related companies and executives

No related entities found.